These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 9788519
1. Differentiating new marijuana use from residual drug excretion in occasional marijuana users. Huestis MA, Cone EJ. J Anal Toxicol; 1998 Oct; 22(6):445-54. PubMed ID: 9788519 [Abstract] [Full Text] [Related]
10. Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence. Goodwin RS, Darwin WD, Chiang CN, Shih M, Li SH, Huestis MA. J Anal Toxicol; 2008 Oct; 32(8):562-9. PubMed ID: 19007504 [Abstract] [Full Text] [Related]
11. Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections. Smith ML, Barnes AJ, Huestis MA. J Anal Toxicol; 2009 May; 33(4):185-9. PubMed ID: 19470219 [Abstract] [Full Text] [Related]
13. Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users. Huestis MA, Blount BC, Milan DF, Newmeyer MN, Schroeder J, Smith ML. Drug Test Anal; 2019 Jul; 11(7):968-975. PubMed ID: 30756523 [Abstract] [Full Text] [Related]
14. Validity testing of the accuPINCH THC test. Jenkins AJ, Darwin WD, Huestis MA, Cone EJ, Mitchell JM. J Anal Toxicol; 1995 Jul; 19(1):5-12. PubMed ID: 7723303 [Abstract] [Full Text] [Related]
20. Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disorders. Duflot T, Vasse M, Guillerme J, Schrapp A, Mory C, Imbert L, Djerada Z, Protais Y, Guillin O, Goetz H, Lamoureux F. Drug Test Anal; 2019 Sep; 11(9):1453-1459. PubMed ID: 31261442 [Abstract] [Full Text] [Related] Page: [Next] [New Search]